Outlook Therapeutics
OTLK
OTLK
30 hedge funds and large institutions have $7.76M invested in Outlook Therapeutics in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 4 closing their positions.
Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$3.03M |
| 2 |
2
Millennium Management
New York
|
$235K |
| 3 |
VF
3
Virtu Financial
New York
|
$144K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$114K |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$349K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $12K | 9,000 | +1,515 | +20% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $9K | 6,765 | +6,765 | New |
|
|
CFGS
28
Concourse Financial Group Securities
Birmingham,
Alabama
| $2K | 1,375 | – | – |
|
|
PWMG
29
Prestige Wealth Management Group
Flemington,
New Jersey
| $2K | 1,250 | – | – |
|
|
RJFSA
30
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | – | -30,000 | Closed |
|
31
LPL Financial
San Diego,
California
| – | – | -20,174 | Closed |
|
|
WG
32
Winton Group
London,
United Kingdom
| – | – | -16,213 | Closed |
|
|
OC
33
Oppenheimer & Co
New York
| – | – | -10,000 | Closed |
|
34
Wells Fargo
San Francisco,
California
| $0 | 394 | +51 | +15% |
|